Jove
Visualize
Contact Us

Related Experiment Videos

Cancer from an unknown primary site.

Jonathan E Dowell

    The American Journal of the Medical Sciences
    |July 16, 2003
    PubMed
    Summary

    This review guides physicians in identifying patients with cancer of unknown primary (CUP) who can benefit from targeted therapies. It covers diagnostic tests, prognosis, and treatment strategies for CUP.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Deciphering small sequence differences in T cell receptor-antigen pairing.

    Nature communications·2026
    Same author

    Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancer.

    Translational lung cancer research·2025
    Same author

    Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core.

    The Prostate·2025
    Same author

    Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial.

    EClinicalMedicine·2025
    Same author

    Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes.

    Nature cancer·2025
    Same author

    Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.

    International journal of radiation oncology, biology, physics·2025
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Oncology
    • Clinical Medicine

    Background:

    • Cancer of unknown primary (CUP) presents a diagnostic and therapeutic challenge in clinical practice.
    • Accurate identification of CUP patients who may benefit from specific treatments is crucial.

    Purpose of the Study:

    • To provide physicians with a framework for identifying patients with CUP who can benefit from specific therapeutic approaches.
    • To review the utility of diagnostic and pathologic tests in the management of CUP.
    • To discuss the prognosis and appropriate treatment strategies for patients diagnosed with CUP.

    Main Methods:

    • Literature review of existing studies and clinical guidelines on cancer of unknown primary.
    • Analysis of diagnostic and pathologic testing utility in CUP patient stratification.
    • Synthesis of current evidence on prognostic factors and treatment options for CUP.

    Main Results:

    • Specific patient subgroups within CUP may benefit from tailored therapeutic strategies.
    • Pathologic and diagnostic tests play a vital role in guiding treatment decisions for CUP.
    • Prognosis and treatment efficacy vary significantly based on CUP characteristics and patient factors.

    Conclusions:

    • Physicians can improve outcomes for select CUP patients by applying evidence-based diagnostic and therapeutic approaches.
    • A systematic approach to evaluating CUP is essential for optimizing patient management.
    • Further research is needed to refine treatment strategies for different CUP subtypes.

    Related Experiment Videos